MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-65 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹198 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-65 Cr | Negative | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹198 Cr | 148.81 | |
| Mar2022 | ₹80 Cr | Positive | |
| Mar2021 | ₹-15 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹12,546.8 Cr | 4.9% | 9.6% | 2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 4.9% |
9.6% |
2.4% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses